XENE Jan 2025 42.500 call
| Previous close | 8.99 |
| Open | N/A |
| Bid | 4.10 |
| Ask | 5.90 |
| Strike | 42.50 |
| Expiry date | 2025-01-17 |
| Day's range | 8.99 - 8.99 |
| Contract range | N/A |
| Volume | |
| Open interest | 93 |
GlobeNewswireXenon Showcases Azetukalner Data at 15th European Epilepsy Congress
Three presentations highlighting long-term data and improved quality of life outcomes in adults with focal onset seizures VANCOUVER, British Columbia and BOSTON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced three poster presentations at the 15th European Epilepsy Congress (EEC) taking place in Rome,
Insider MonkeyXenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now
We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other mid-cap healthcare stocks. Global Healthcare Market: Growth Projections, Challenges, and Tech-Driven Innovations According to projections by ReportLinker, the market for healthcare […]
Simply Wall St.We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
